Literature DB >> 3337449

Clinically important respiratory effects of dust exposure and smoking in British coal miners.

W M Marine1, D Gurr, M Jacobsen.   

Abstract

A unique data set of 3,380 British coal miners has been reanalyzed with major focus on nonpneumoconiotic respiratory conditions. The aim was to assess the independent contribution of smoking and exposure to respirable dust to clinically significant measures of respiratory dysfunction. Exposure to coal-mine dust was monitored over a 10-yr period. Medical surveys provided estimates of prior dust exposure and recorded respiratory symptoms. Each man's FEV1 was compared with the level predicted for his age and height by an internally derived prediction equation for FEV1. Four respiratory indices were considered at the end of the 10-yr period: FEV1 less than 80%, chronic bronchitis, chronic bronchitis with FEV1 less than 80%, and FEV1 less than 65%. Results were uniformly incorporated into logistic regression equations for each condition. The equations include coefficients for age, dust, and when indicated, an interaction term for age and dust. Dust-related increases in prevalence of each of the 4 conditions were statistically significant and were similar for smokers and nonsmokers at the mean age (47 yr). There was no evidence that smoking potentiates the effect of exposure to dust. Estimates of prevalences at the mean age of all 4 measures of respiratory dysfunction were greater in smokers. At intermediate and high dust exposure the prevalence of the 4 conditions in nonsmokers approached the prevalence in smokers at hypothetically zero dust exposure. Both smoking and dust exposure can cause clinically important respiratory dysfunction and their separate contributions to obstructive airway disease in coal miners appear to be additive.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337449     DOI: 10.1164/ajrccm/137.1.106

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  33 in total

1.  Increased risk of obstructive pulmonary disease in tunnel workers.

Authors:  B Ulvestad; B Bakke; E Melbostad; P Fuglerud; J Kongerud; M B Lund
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  Cumulative exposure to dust causes accelerated decline in lung function in tunnel workers.

Authors:  B Ulvestad; B Bakke; W Eduard; J Kongerud; M B Lund
Journal:  Occup Environ Med       Date:  2001-10       Impact factor: 4.402

3.  Respiratory symptoms and intensity of occupational dust exposure.

Authors:  Eric Garshick; Francine Laden; Jaime E Hart; Marilyn L Moy
Journal:  Int Arch Occup Environ Health       Date:  2004-09-10       Impact factor: 3.015

4.  Forced expiratory volume in one second: why dichotomise?

Authors:  J Vestbo; K M Knudsen; F V Rasmussen
Journal:  Br J Ind Med       Date:  1992-06

5.  Dust related risks of clinically relevant lung functional deficits.

Authors:  H A Cowie; B G Miller; R G Rawbone; C A Soutar
Journal:  Occup Environ Med       Date:  2006-05       Impact factor: 4.402

Review 6.  Coal mining and chronic obstructive pulmonary disease: a review of the evidence.

Authors:  D Coggon; A Newman Taylor
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

7.  Chronic bronchitis in textile workers.

Authors:  R M Niven; A M Fletcher; C A Pickering; D Fishwick; C J Warburton; J C Simpson; H Francis; L A Oldham
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

8.  Coalmining, emphysema, and compensation.

Authors:  A Seaton
Journal:  Br J Ind Med       Date:  1990-07

9.  Prevalence and predictors of work related respiratory symptoms in workers exposed to organic dusts.

Authors:  J C Simpson; R M Niven; C A Pickering; A M Fletcher; L A Oldham; H M Francis
Journal:  Occup Environ Med       Date:  1998-10       Impact factor: 4.402

10.  Association of years of occupational quartz exposure with spirometric airflow limitation in Norwegian men aged 30-46 years.

Authors:  S Humerfelt; G E Eide; A Gulsvik
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.